Lipidio Pharmaceuticals
Lipidio Pharmaceuticals is a biopharmaceutical company focused on transforming molecules into the right medicines for dermatological and metabolic diseases. They are pioneering a unique approach to treat obesity by targeting the skin as an endocrine organ, developing a topical drug that activates the body's metabolism to burn fat. The company is also working on therapeutics for conditions like sebaceous hyperplasia, NASH, and Prader Willi syndrome, with a focus on unmet medical needs. Their leadership team has extensive experience in drug development, research, and biotech industry collaborations.
Industries
Nr. of Employees
small (1-50)
Lipidio Pharmaceuticals
3570 Carmel Mountain Rd. Suite 200, San Diego, CA 92130
Patents
Methods of treating a patient afflicted with non-alcoholic steatohepatitis (NASH)
US-11865113-B2
View Details
Methods of treating a patient afflicted with non-alcoholic steatohepatitis (NASH)
US-11865113-B2
View DetailsProducts
GDD3898 (clinical-stage topical therapeutic candidate)
A clinical-stage, topical small-molecule therapeutic candidate in Phase 2 development for dermatologic indications (e.g., sebaceous hyperplasia, acne) and being investigated for metabolic indications (obesity, NASH, genetic obesity disorders).
GDD3898 (clinical-stage topical therapeutic candidate)
A clinical-stage, topical small-molecule therapeutic candidate in Phase 2 development for dermatologic indications (e.g., sebaceous hyperplasia, acne) and being investigated for metabolic indications (obesity, NASH, genetic obesity disorders).
Services
Sourcing and acquiring candidate molecules followed by optimization of preclinical and clinical development plans.
In vivo efficacy studies, mechanism-of-action investigations, and nonclinical safety programs to support IND-enabling activities.
Design and conduct of early-phase clinical trials (Phase 1, Phase 1B, Phase 2) in dermatology and metabolic indications.
Regulatory planning and preparation of submissions to health authorities to support clinical progression.
Pharmaceutical sciences support for formulation design and CMC activities across routes of administration including topical products.
Sourcing and acquiring candidate molecules followed by optimization of preclinical and clinical development plans.
In vivo efficacy studies, mechanism-of-action investigations, and nonclinical safety programs to support IND-enabling activities.
Design and conduct of early-phase clinical trials (Phase 1, Phase 1B, Phase 2) in dermatology and metabolic indications.
Regulatory planning and preparation of submissions to health authorities to support clinical progression.
Pharmaceutical sciences support for formulation design and CMC activities across routes of administration including topical products.
Expertise Areas
- Topical therapeutic development
- Clinical trial management for dermatology and metabolic disease
- Nonclinical development and mechanism-of-action studies
- CMC and formulation development
Key Technologies
- Topical drug delivery
- Skin-targeted endocrine modulation
- Small-molecule therapeutics
- Animal disease models